本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Centessa Pharmaceuticals plc

13.50
-0.2100-1.53%
盘后13.900.4000+2.96%18:51 EDT
成交量:63.55万
成交额:869.06万
市值:17.98亿
市盈率:-6.56
高:14.06
开:13.65
低:13.15
收:13.71
数据加载中...
2025/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/08

重要事件披露

Form 8-K - Current report
2024/12/30

重要事件披露

Form 8-K - Current report
2024/12/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]